Work

Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma

Year: 2018

Type: article

Source: Journal of Controlled Release

DOI: 10.1016/j.jconrel.2018.01.004

Authors: Motao Zhu, Xilai Ding, Ruifang Zhao, Xuewu Liu, Haifa Shen, Chunmei Cai, Mauro Ferrari, Helen Y. Wang, Rong-Fu Wang

Institutions: Houston Methodist, National Center for Nanoscience and Technology

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Cancer Prevention and Research Institute of Texas, National Institutes of Health, National Institute on Drug Abuse, National Cancer Institute

Awards: G1736252752, G1736293207, CPRIT Core for RNA Therapeutics and Research, G5354192954, Identification of novel immune targets and neoantigens for development of immunotherapy for breast cancer, G5989595523, Immunotherapy targeting triple negative breast cancer using NY-ESO-1-specific TCRs and blockade of immune suppression, G9000162200

OpenAlex ID: W2783718972

FWCI: 2.965

Cites: 47

Cited by: 72

Related to: 10